Efficacy Study of Botox to Treat Neuropathic Pain

• Status: Completed
• Trial end date: 2007-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Objectives : to investigate the analgesic effects and safety of intradermal botulinum toxin A injection in the treatment of focal painful neuropathies (eg, postherpetic neuralgia, nerve trauma)

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Ambroise Paré Paris
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• daily pain for at least 6 months of at least moderate intensity clearly attributed to the nerve lesion

• limited area of pain

• mechanical allodynia in the painful area

Exclusion Criteria:

• contraindication to BTXA formulation

• coagulation disorders

• another painful condition

• current major depression

• history of drug or alcohol abuse

• compensation claim or litigation

• facial neuropathic pain